This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is supporting research to investigate the contributions and impact of neutrophil activity in a comorbid model of Alzheimer's disease (AD) and vascular contributions to cognitive impairment and dementia (VCID). The key objectives are to examine the neutrophil response to AD, VCID, and...
This Project Grant award for $2,398,590.00, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research to investigate the role of brain microcirculation and capillary endothelial cell energetics in the development of vascular cognitive impairment and dementia (VCID) observed in Alzheimer's disease (AD) and AD-related dementias. The...
This federal Project Grant award, issued by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $4,693,249 to the University of California, Los Angeles (UCLA) to conduct research on defining the molecular spectrum of white matter vascular lesions that drive vascular cognitive impairment and dementia (VCID). The project aims to develop a better understanding of...
This Project Grant award of $5,949,022, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will fund research to identify novel therapeutic targets for treating cerebral amyloid angiopathy (CAA) and vascular contributions to cognitive impairment and dementia (VCID). The research, led by the Jackson Laboratory with sub-awards to Emory University, Rush...
This $9,631,026 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research at Northwestern University to investigate the relationship between Alzheimer's disease and atherosclerosis. The research aims to conduct a comprehensive analysis of the structural, molecular, and functional aspects of the brain's vasculature in mouse models of...
This $338,527 Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) supports research to understand the role of inhibitory interneurons in the pathophysiology of Alzheimer's disease (AD) and related dementias (ADRD). The key objectives are to: 1) Identify disrupted interneuron gene expression in post-mortem AD brain tissue, 2) Characterize inhibitory dysfunction in AD-derived induced interneurons in vitro, and 3) Assess the impact of transplanting healthy...
This federal Project Grant award R21NS135390 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders CFDA program (93.853), provides $444,555.00 to Cornell University for a research project titled "Reduced Alzheimer's Disease Progression and Neutrophil Adhesion via Competition Using Neutrophil-Derived or Engineered Nanoparticles." The project aims to develop a novel therapeutic...
This $1,120,805 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders federal grant program (CFDA 93.853), will support research to investigate how prior SARS-CoV-2 infection may increase the risk of vascular contributions to cognitive impairment and dementia (VCID). The research aims to: Determine how prior SARS-CoV-2 infection influences blood-brain barrier...
This Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $10,847,672 to the J. David Gladstone Institutes, a non-profit biomedical research organization, to investigate the vascular-immune mechanisms underlying cerebral amyloid angiopathy (CAA) and Alzheimer's disease pathology. The research aims to elucidate the key microglial mechanisms regulating the formation of vascular CAA versus parenchymal amyloid-beta plaques, define single-cell and...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $185,913 to Trustees of Boston University to examine sex differences in vascular contributions to cognitive impairment and dementia (VCID) and Alzheimer's disease (AD). The research aims to identify sex-specific patterns of white matter integrity, functional brain connectivity, and cognitive...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $631,577.00 to the University of Miami to conduct research on the role of neutrophils in vascular inflammation and cognitive impairment in Alzheimer's disease (AD) and vascular contributions to cognitive impairment and dementia (VCID).
The key research objectives are to: 1) use longitudinal in vivo two-photon imaging to determine how and when neutrophils become reactive in VCID, AD, and mixed AD mouse models; 2) utilize single-cell sequencing of neutrophils to identify disease-associated neutrophil subpopulations and elucidate the molecular mechanisms driving neutrophil changes; and 3) functionally test if activated neutrophils can be stopped to slow disease progression. The project involves a sub-award to Mayo Clinic Jacksonville for single-cell RNA sequencing experiments, and a sub-award to Florida International University for glycoproteomic and glycomic analyses of neutrophils from the mouse models. The award period runs from September 17, 2024 to August 31, 2029.